SAB Biotherapeutics, Inc. has filed 414 documents with the SEC available on Filing Fan. Browse annual reports (10-K), quarterly reports (10-Q), earnings releases (8-K), proxy statements, and more on Filing Fan. Filing Fan provides income statements, balance sheets, cash flow statements, and segment data parsed directly from EDGAR filings. All financial data is sourced from publicly available SEC regulatory filings.
| Form | Date | Description |
|---|---|---|
| 8-K | 2026-07-07 | Regulation FD Disclosure; Financial Statements and Exhibits |
| 4 | 2026-06-26 | Statement of Changes in Beneficial Ownership |
| 8-K | 2026-06-18 | Submission of Matters to a Vote of Security Holders |
| SC 13G | 2026-05-15 | Beneficial Ownership Report (Passive) |
| SC 13G/A | 2026-05-15 | Beneficial Ownership Report (Passive, Amended) |
| SC 13G | 2026-05-15 | Beneficial Ownership Report (Passive) |
| 10-Q | 2026-05-12 | Quarterly Report |
| 8-K | 2026-05-04 | Entry into a Material Definitive Agreement; Financial Statements and Exhibits |
| SC 13G | 2026-05-01 | Beneficial Ownership Report (Passive) |
| DEF 14A | 2026-04-30 | Proxy Statement |